This inventor holds 1 USPTO granted patent. Top assignee: Nissan Chemical Industries Limited. Active years: 1983.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1983
Title: The Innovative Contributions of Shin Yamada
Introduction
Shin Yamada is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of pharmaceuticals through his innovative methods. His work focuses on the preparation of important chemical compounds that serve as intermediates in drug development.
Latest Patents
One of Shin Yamada's key patents is titled "Method for preparing 4-hydroxyphenylacetic acid." This patent describes a novel process for synthesizing 4-hydroxyphenylacetic acid, which is valuable in pharmaceutical applications. The method involves several steps, including the reaction of benzyl phenyl ether with formaldehyde and hydrogen chloride to produce 4-benzyloxybenzyl chloride. This intermediate is then reacted with an alkali metal cyanide in a suitable solvent to yield 4-benzyloxyphenylacetonitrile. Finally, the compound is hydrolyzed in the presence of an acid catalyst to obtain the desired product. Shin Yamada holds 1 patent for this innovative process.
Career Highlights
Shin Yamada is associated with Nissan Chemical Industries Limited, where he applies his expertise in chemical synthesis. His work at the company has contributed to advancements in pharmaceutical chemistry and has helped in the development of new therapeutic agents.
Collaborations
Shin Yamada has collaborated with Motoo Mutsukado, a fellow researcher, to enhance the scope of their work in chemical innovations. Their partnership has led to the exploration of new methodologies in the preparation of pharmaceutical intermediates.
Conclusion
Shin Yamada's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to advancing chemical synthesis. His work continues to impact the development of important pharmaceutical compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile